Keywords: japan, tobacco, continue, clinical, trials, anti-inflammatory, alone

Japan Tobacco to continue clinical trials of anti-inflammatory alone

Article | 26 July 2000

Print This

Japan Tobacco has said that it plans to continue clinical development ofthe oral anti-inflammatory JTE-522, licensed from the RW Johnson ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in